Tofacitinib as a Treatment for Refractory Dermatomyositis: A Case Report

Open Journal of Rheumatology and Autoimmune Diseases

ISSN Print: 2163-9914
ISSN Online: 2164-005X
www.scirp.org/journal/ojra
E-mail: ojra@scirp.org

Citations

Journals Menu

Aims & Scope
Articles
Archive
Editorial Board
Publication Fees
Indexing

"Tofacitinib as a Treatment for Refractory Dermatomyositis: A Case Report"
written by Samuel Katsuyuki Shinjo, Fernando Henrique Carlos de Souza,
published by Open Journal of Rheumatology and Autoimmune Diseases, Vol.10 No.1, 2020

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Use of JAK Inhibitors in Dermatomyositis: A Systematic Literature Review
	Clinical and …, 2023

[2]	Up-to-date treatment and management of myositis
	2020

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Open Journal of Rheumatology and Autoimmune Diseases

Open Journal of Rheumatology and Autoimmune Diseases

Journals Menu

Guidelines & Policies

Home

About SCIRP

Service

Policies

[1]	Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons Expert Opinion on Pharmacotherapy, 2024 DOI:10.1080/14656566.2024.2392021

[2]	Up-to-date treatment and management of myositis Current Opinion in Rheumatology, 2020 DOI:10.1097/BOR.0000000000000745